ticagrelor
SCAD-20160901
Phase 3 small_molecule active
Quick answer
ticagrelor for Coronary Artery Disease is a Phase 3 program (small_molecule) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- First Tracks Biotherapeutics
- Indication
- Coronary Artery Disease
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active